JP Morgan Chase
PRVL

JP Morgan Chase’s Prevail Therapeutics Inc. Common Stock PRVL Stock Holding History

JP Morgan Chase’s Portfolio PRVL Stock Details PRVL Fund Activity
Upgrade to unlock
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
2020
Q4 		$175K Sell
2020
Q3 		$463K Buy
2020
Q2 		$585K Buy
2020
Q1 		$389K Buy
2019
Q4 		$223K Buy
2019
Q3 		$30K Buy